I think it's important to have one central repository, with everyone collecting data using the same methodology and the same case definitions. You'll find different epidemiological patterns based on where you are in the country. We know, for example, in the west there were higher incidents of antimicrobial resistance way back when with MRSA, for example. Moving across to the east, those rates were lower. There are differences across the country in rates.
By having a standardized set of case definitions, where it's funnelled up to one central repository where that information can be distilled down so that it is usable by clinicians and shared broadly across the country, we're able to benchmark our own individual locations much better.